\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ sided\\ facial\\ droop\\ with\\ noted\\ drooling\\.\ \(0\)\
\-\ inr\\ 1\\.3\ \(0\)\
\-\ the\\ patient\\ was\\ anticoagulated\\,\\ then\\ continued\\ on\\ long\\-term\\ warfarin\\ therapy\\ with\\ goal\\ inr\\ of\\ 3\\.0\\.\ \(0\)\
\-\ \\â\\€\\¢\\ there\\ is\\ a\\ low\\-attenuating\\ mass\\ in\\ the\\ left\\ atrial\\ appendage\\.\\ this\\ is\\ most\\ suggestive\\ of\\ a\\ thrombus\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ the\\ trileaflet\\ aortic\\ valve\\ is\\ calcified\\ and\\ stenotic\\,\\ with\\ a\\ systolic\\ valve\\ area\\ of\\ 1\\.4\\-1\\.7cm\\^2\\.\ \(0\)\
\-\ \\â\\€\\¢\\ there\\ are\\ no\\ infective\\ vegetations\\ present\\ on\\ either\\ the\\ aortic\\ or\\ mitral\\ valves\\.\ \(0\)\
\-\ left\\ atrial\\ appendage\\ thrombus\ \(0\)\
\-\ infective\\ endocarditis\ \(3\)\
\-\ left\\ atrial\\ myxoma\ \(1\)\
\-\ papillary\\ fibroelastoma\ \(2\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 80\\ year\\-old\\ man\\ with\\ a\\ known\\ history\\ of\\ rate\\-controlled\\ atrial\\ fibrillation\\ and\\ aortic\\ stenosis\\ presented\\ one\\ week\\ prior\\ to\\ study\\ with\\ facial\\ droop\\.\ \(1\)\
\-\ the\\ initial\\ brain\\ mri\\ showed\\ scattered\\ lesions\\ consistent\\ with\\ thromboembolic\\ phenomena\\.\ \(0\)\
\-\ this\\ patient\\ had\\ suspected\\ thromboembolic\\ disease\\ with\\ a\\ cardiac\\ origin\\.\\ in\\ a\\ patient\\ of\\ this\\ age\\ and\\ with\\ his\\ history\\ of\\ atrial\\ fibrillation\\ and\\ aortic\\ stenosis\\,\\ left\\ atrial\\ thrombus\\ and\\ infective\\ endocarditis\\ were\\ high\\ on\\ the\\ differential\\ for\\ the\\ embolic\\ source\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ two\\ transthoracic\\ echocardiograms\\ \\(ttes\\)\\ evaluating\\ for\\ possible\\ endocarditis\\.\\ both\\ ttes\\ were\\ negative\\ for\\ atrial\\ thrombus\\,\\ and\\ neither\\ could\\ effectively\\ image\\ the\\ aortic\\ valve\\ due\\ to\\ the\\ high\\ level\\ of\\ valvular\\ calcification\\ present\\.\\ it\\ should\\ be\\ noted\\ that\\ tte\\ has\\ a\\ relatively\\ low\\ sensitivity\\ \\(high\\ false\\ negative\\ rate\\)\\ for\\ visualizing\\ left\\ atrial\\ appendage\\ thrombi\\ compared\\ to\\ tee\\ and\\ cardiac\\-gated\\ ct\\.\ \(0\)\
\-\ a\\ transesophageal\\ echocardiogram\\ was\\ bypassed\\ after\\ the\\ patient\\ was\\ deemed\\ not\\ to\\ be\\ a\\ good\\ surgical\\ candidate\\ \\(based\\ on\\ age\\ and\\ comorbidities\\)\\;\\ this\\ cardiac\\-gated\\ ct\\ scan\\ was\\ later\\ performed\\ instead\\ to\\ evaluate\\ for\\ the\\ embolic\\ source\\.\\ the\\ ct\\ scan\\ showed\\ no\\ evidence\\ of\\ infective\\ endocarditis\\,\\ but\\ did\\ reveal\\ a\\ filling\\ defect\\ within\\ the\\ left\\ atrial\\ appendage\\.\\ of\\ note\\,\\ single\\-phase\\ contrast\\ imaging\\ with\\ cardiac\\-gated\\ ct\\ can\\ have\\ a\\ falsely\\ positive\\ filling\\ defect\\ in\\ the\\ left\\ atrial\\ appendage\\,\\ especially\\ in\\ cases\\ of\\ atrial\\ fibrillation\\ when\\ the\\ atria\\ may\\ be\\ dilated\\ and\\/or\\ there\\ is\\ little\\ contractility\\ to\\ allow\\ adequate\\ contrast\\ mixing\\ within\\ the\\ appendage\\.\\ key\\ to\\ this\\ study\\ is\\ the\\ late\\-phase\\ imaging\\,\\ which\\ showed\\ contrast\\ filling\\ the\\ atrial\\ appendage\\ and\\ highlighting\\ the\\ presence\\ of\\ a\\ thrombus\\.\\ this\\ finding\\ was\\ pathognomonic\\.\\ \ \(0\)\
\-\ cardiac\\ tumors\\,\\ including\\ atrial\\ myxomas\\ and\\ papillary\\ fibroelastomas\\ \\(as\\ well\\ as\\ metastatic\\ disease\\)\\,\\ are\\ other\\ possibilities\\,\\ but\\ are\\ considerably\\ more\\ rare\\;\\ thus\\,\\ they\\ remain\\ low\\ on\\ the\\ differential\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ atrial\\:\\ 0\\.13567368300045432\ \(0\)\
\-\ appendage\\:\\ 0\\.11056815495563711\ \(0\)\
\-\ infective\\:\\ 0\\.07092338007490795\ \(0\)\
\-\ endocarditis\\:\\ 0\\.05555881766503587\ \(0\)\
\-\ cardiac\\-gated\\:\\ 0\\.05525231123125338\ \(0\)\
\-\ thrombus\\:\\ 0\\.05150010445866627\ \(0\)\
\-\ ttes\\:\\ 0\\.04207884689244152\ \(0\)\
\-\ aortic\\:\\ 0\\.041276039967714624\ \(0\)\
\-\ fibrillation\\:\\ 0\\.038766021782608656\ \(0\)\
\-\ valve\\:\\ 0\\.030588713425034567\ \(0\)\
\-\ thromboembolic\\:\\ 0\\.029481914531509498\ \(0\)\
\-\ droop\\:\\ 0\\.028024245559904813\ \(0\)\
\-\ inr\\:\\ 0\\.025535954754972657\ \(0\)\
\-\ embolic\\:\\ 0\\.02484296186788675\ \(0\)\
\-\ filling\\:\\ 0\\.0246317900927136\ \(0\)\
\-\ source\\:\\ 0\\.021534383440392976\ \(0\)\
\-\ trileaflet\\:\\ 0\\.02103942344622076\ \(0\)\
\-\ 1\\.4\\-1\\.7cm\\^2\\:\\ 0\\.02103942344622076\ \(0\)\
\-\ rate\\-controlled\\:\\ 0\\.02103942344622076\ \(0\)\
\-\ single\\-phase\\:\\ 0\\.02103942344622076\ \(0\)\
\-\ late\\-phase\\:\\ 0\\.02103942344622076\ \(0\)\
\-\ papillary\\:\\ 0\\.02070731078514698\ \(0\)\
\-\ showed\\:\\ 0\\.02006064392308136\ \(0\)\
\-\ low\\-attenuating\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ bypassed\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ falsely\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ contractility\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ highlighting\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ myxomas\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ fibroelastomas\\:\\ 0\\.019385134232473875\ \(0\)\
\-\ fibroelastoma\\:\\ 0\\.01841743707708446\ \(0\)\
\-\ left\\:\\ 0\\.018254993208074746\ \(0\)\
\-\ facial\\:\\ 0\\.01773580905079857\ \(0\)\
\-\ vegetations\\:\\ 0\\.017730845018726987\ \(0\)\
\-\ echocardiograms\\:\\ 0\\.017730845018726987\ \(0\)\
\-\ mixing\\:\\ 0\\.017730845018726987\ \(0\)\
\-\ tee\\:\\ 0\\.01719828284375274\ \(0\)\
\-\ transesophageal\\:\\ 0\\.01719828284375274\ \(0\)\
\-\ visualizing\\:\\ 0\\.016763147863337574\ \(0\)\
\-\ high\\:\\ 0\\.016743766547089374\ \(0\)\
\-\ transthoracic\\:\\ 0\\.016395246479501635\ \(0\)\
\-\ considerably\\:\\ 0\\.016395246479501635\ \(0\)\
\-\ effectively\\:\\ 0\\.016076555804980103\ \(0\)\
\-\ tte\\:\\ 0\\.016076555804980103\ \(0\)\
\-\ deemed\\:\\ 0\\.016076555804980103\ \(0\)\
\-\ stenosis\\:\\ 0\\.015978321159099605\ \(0\)\
\-\ thrombi\\:\\ 0\\.015795450707948158\ \(0\)\
\-\ comorbidities\\:\\ 0\\.015795450707948158\ \(0\)\
\-\ cardiac\\:\\ 0\\.015536213808835181\ \(0\)\
\-\ defect\\:\\ 0\\.015268483657756213\ \(0\)\
\-\ drooling\\:\\ 0\\.015108858649590686\ \(0\)\
\-\ phenomena\\:\\ 0\\.015108858649590686\ \(0\)\
\-\ atria\\:\\ 0\\.014917825934379382\ \(0\)\
\-\ warfarin\\:\\ 0\\.014576296474616439\ \(0\)\
\-\ anticoagulated\\:\\ 0\\.014422266591233215\ \(0\)\
\-\ myxoma\\:\\ 0\\.014422266591233215\ \(0\)\
\-\ valvular\\:\\ 0\\.014277577756349124\ \(0\)\
\-\ possibilities\\:\\ 0\\.014277577756349124\ \(0\)\
\-\ stenotic\\:\\ 0\\.014012122779952407\ \(0\)\
\-\ this\\:\\ 0\\.013763301383973267\ \(0\)\
\-\ contrast\\:\\ 0\\.01369529131366042\ \(0\)\
\-\ neither\\:\\ 0\\.013662233820067262\ \(0\)\
\-\ study\\:\\ 0\\.01342067473441508\ \(0\)\
\-\ goal\\:\\ 0\\.013263536720632496\ \(0\)\
\-\ 1\\.3\\:\\ 0\\.01317346433881186\ \(0\)\
\-\ differential\\:\\ 0\\.01294968892292568\ \(0\)\
\-\ false\\:\\ 0\\.012922007260869553\ \(0\)\
\-\ instead\\:\\ 0\\.012843749927163133\ \(0\)\
\-\ valves\\:\\ 0\\.012767977377486328\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.012623288542602236\ \(0\)\
\-\ allow\\:\\ 0\\.012623288542602236\ \(0\)\
\-\ candidate\\:\\ 0\\.012554105877033615\ \(0\)\
\-\ mitral\\:\\ 0\\.012486872280454388\ \(0\)\
\-\ age\\:\\ 0\\.012414846422645854\ \(0\)\
\-\ negative\\:\\ 0\\.012181957810858589\ \(0\)\
\-\ echocardiogram\\:\\ 0\\.012062812191582185\ \(0\)\
\-\ key\\:\\ 0\\.012007944606320375\ \(0\)\
\-\ was\\:\\ 0\\.011793287854578602\ \(0\)\
\-\ sensitivity\\:\\ 0\\.011519175125064974\ \(0\)\
\-\ remain\\:\\ 0\\.011432378838260976\ \(0\)\
\-\ scan\\:\\ 0\\.011418956851708729\ \(0\)\
\-\ ct\\:\\ 0\\.011411013397537403\ \(0\)\
\-\ a\\:\\ 0\\.011358466877859703\ \(0\)\
\-\ systolic\\:\\ 0\\.011348628671646968\ \(0\)\
\-\ evaluating\\:\\ 0\\.011348628671646968\ \(0\)\
\-\ low\\:\\ 0\\.011342090944469687\ \(0\)\
\-\ long\\-term\\:\\ 0\\.011267718047122668\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.011219673161784401\ \(0\)\
\-\ little\\:\\ 0\\.011076685331911362\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.01104024745093096\ \(0\)\
\-\ adequate\\:\\ 0\\.010934157325463578\ \(0\)\
\-\ metastatic\\:\\ 0\\.01026782531558993\ \(0\)\
\-\ patient\\:\\ 0\\.01022186075079222\ \(0\)\
\-\ thus\\:\\ 0\\.010145991008350029\ \(0\)\
\-\ disease\\:\\ 0\\.010000507455005043\ \(0\)\
\-\ noted\\:\\ 0\\.00966788156779281\ \(0\)\
\-\ \\;\\:\\ 0\\.00966788156779281\ \(0\)\
\-\ 80\\:\\ 0\\.009593622621407534\ \(0\)\
\-\ imaging\\:\\ 0\\.009556438302890706\ \(0\)\
\-\ scattered\\:\\ 0\\.00949698452748215\ \(0\)\
\-\ be\\:\\ 0\\.009435012338978014\ \(0\)\
\-\ origin\\:\\ 0\\.009350068315073\ \(0\)\
\-\ were\\:\\ 0\\.009261509960333753\ \(0\)\
\-\ present\\:\\ 0\\.009212452286070075\ \(0\)\
\-\ there\\:\\ 0\\.009105361979462927\ \(0\)\
\-\ reveal\\:\\ 0\\.009080866658401533\ \(0\)\
\-\ either\\:\\ 0\\.008882501725918224\ \(0\)\
\-\ continued\\:\\ 0\\.008782147940134216\ \(0\)\
\-\ suspected\\:\\ 0\\.008782147940134216\ \(0\)\
\-\ calcified\\:\\ 0\\.008754233764088414\ \(0\)\
\-\ relatively\\:\\ 0\\.008726642302510667\ \(0\)\
\-\ good\\:\\ 0\\.008726642302510667\ \(0\)\
\-\ suggestive\\:\\ 0\\.008712965274565596\ \(0\)\
\-\ for\\:\\ 0\\.008700574566142184\ \(0\)\
\-\ but\\:\\ 0\\.00869929976626987\ \(0\)\
\-\ on\\:\\ 0\\.008638317569993175\ \(0\)\
\-\ compared\\:\\ 0\\.008632509290455066\ \(0\)\
\-\ and\\/or\\:\\ 0\\.008619359753913373\ \(0\)\
\-\ especially\\:\\ 0\\.008394274600044061\ \(0\)\
\-\ are\\:\\ 0\\.008340385722168987\ \(0\)\
\-\ evaluate\\:\\ 0\\.00824397675001688\ \(0\)\
\-\ rate\\:\\ 0\\.007949215967722776\ \(0\)\
\-\ rare\\:\\ 0\\.007919690211630779\ \(0\)\
\-\ note\\:\\ 0\\.007871278108596159\ \(0\)\
\-\ within\\:\\ 0\\.007781056841938337\ \(0\)\
\-\ based\\:\\ 0\\.00777730396722425\ \(0\)\
\-\ \\,\\:\\ 0\\.007753032902643076\ \(0\)\
\-\ tumors\\:\\ 0\\.007660420901361578\ \(0\)\
\-\ sided\\:\\ 0\\.007540636308225885\ \(0\)\
\-\ could\\:\\ 0\\.007524004639213729\ \(0\)\
\-\ year\\-old\\:\\ 0\\.007491085015986197\ \(0\)\
\-\ dilated\\:\\ 0\\.007410719347474054\ \(0\)\
\-\ calcification\\:\\ 0\\.007402829638322504\ \(0\)\
\-\ presence\\:\\ 0\\.007402829638322504\ \(0\)\
\-\ later\\:\\ 0\\.007363767639601251\ \(0\)\
\-\ did\\:\\ 0\\.007363767639601251\ \(0\)\
\-\ including\\:\\ 0\\.007363767639601251\ \(0\)\
\-\ they\\:\\ 0\\.007348320110948225\ \(0\)\
\-\ then\\:\\ 0\\.007257677514133866\ \(0\)\
\-\ to\\:\\ 0\\.007134789401195474\ \(0\)\
\-\ underwent\\:\\ 0\\.00699808123025828\ \(0\)\
\-\ the\\:\\ 0\\.006928961763188883\ \(0\)\
\-\ week\\:\\ 0\\.006926051117728468\ \(0\)\
\-\ \\(\\:\\ 0\\.0068960546658125114\ \(0\)\
\-\ possible\\:\\ 0\\.0068686926465013655\ \(0\)\
\-\ \\)\\:\\ 0\\.006811815676499333\ \(0\)\
\-\ cases\\:\\ 0\\.00679429800472824\ \(0\)\
\-\ initial\\:\\ 0\\.006757952609258492\ \(0\)\
\-\ is\\:\\ 0\\.00670991382320675\ \(0\)\
\-\ positive\\:\\ 0\\.006617865370606484\ \(0\)\
\-\ finding\\:\\ 0\\.006572939152836472\ \(0\)\
\-\ should\\:\\ 0\\.0065016910307608596\ \(0\)\
\-\ known\\:\\ 0\\.006453582540486443\ \(0\)\
\-\ area\\:\\ 0\\.006448296525380113\ \(0\)\
\-\ image\\:\\ 0\\.006370379871831983\ \(0\)\
\-\ as\\:\\ 0\\.006169821030520896\ \(0\)\
\-\ brain\\:\\ 0\\.006136877143920673\ \(0\)\
\-\ his\\:\\ 0\\.005878016772427046\ \(0\)\
\-\ level\\:\\ 0\\.005878016772427046\ \(0\)\
\-\ two\\:\\ 0\\.005840886008630085\ \(0\)\
\-\ when\\:\\ 0\\.005840886008630085\ \(0\)\
\-\ performed\\:\\ 0\\.005686344465936323\ \(0\)\
\-\ history\\:\\ 0\\.005633482280224742\ \(0\)\
\-\ presented\\:\\ 0\\.005559326097905512\ \(0\)\
\-\ one\\:\\ 0\\.00552680521076526\ \(0\)\
\-\ lesions\\:\\ 0\\.005459571614186033\ \(0\)\
\-\ therapy\\:\\ 0\\.005452603332316499\ \(0\)\
\-\ due\\:\\ 0\\.005442188909195321\ \(0\)\
\-\ evidence\\:\\ 0\\.0053471183373911164\ \(0\)\
\-\ prior\\:\\ 0\\.005236545995709698\ \(0\)\
\-\ both\\:\\ 0\\.005208114536243726\ \(0\)\
\-\ more\\:\\ 0\\.005100659449432378\ \(0\)\
\-\ consistent\\:\\ 0\\.005000711858785688\ \(0\)\
\-\ man\\:\\ 0\\.004823226355823387\ \(0\)\
\-\ most\\:\\ 0\\.004708437092429776\ \(0\)\
\-\ other\\:\\ 0\\.004700807992129949\ \(0\)\
\-\ mri\\:\\ 0\\.004685622565428687\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0046831010281155605\ \(0\)\
\-\ can\\:\\ 0\\.004625829003506133\ \(0\)\
\-\ well\\:\\ 0\\.004613558360307043\ \(0\)\
\-\ it\\:\\ 0\\.004584363686236317\ \(0\)\
\-\ may\\:\\ 0\\.004473337395938243\ \(0\)\
\-\ have\\:\\ 0\\.004416319996098071\ \(0\)\
\-\ had\\:\\ 0\\.004400596227304793\ \(0\)\
\-\ and\\:\\ 0\\.004296157654706884\ \(0\)\
\-\ surgical\\:\\ 0\\.004286925465993923\ \(0\)\
\-\ after\\:\\ 0\\.0042195732759169515\ \(0\)\
\-\ no\\:\\ 0\\.0041071319842663585\ \(0\)\
\-\ in\\:\\ 0\\.004022885251935608\ \(0\)\
\-\ has\\:\\ 0\\.003829832865141475\ \(0\)\
\-\ which\\:\\ 0\\.003807027654516823\ \(0\)\
\-\ that\\:\\ 0\\.00352262703713323\ \(0\)\
\-\ of\\:\\ 0\\.0030585723359853765\ \(0\)\
\-\ not\\:\\ 0\\.0029470612690738317\ \(0\)\
\-\ mass\\:\\ 0\\.0028364224509488415\ \(0\)\
\-\ with\\:\\ 0\\.002513216192861593\ \(0\)\
\-\ or\\:\\ 0\\.0023902690906055075\ \(0\)\
\-\ \\.\\:\\ 0\\.0016097641667054397\ \(0\)\
